Ballew Advisors’s Inogen INGN Stock Holding History

Ballew Advisors’s Portfolio INGN Stock Details INGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-10	Closed	-$2K	–	266
2018 Q3	$2K	Buy	+10	New	+$2.31K	﹤0.01%	407

Other funds holding INGN

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Ballew Advisors's INGN Position: Q4 2018 in Review

Ballew Advisors sold out of Inogen (INGN) in Q4 2018, closing a stake of 10 shares — an estimated $2K sold.

Ballew Advisors first reported a position in INGN in Q3 2018 and held it in 1 quarter. The position peaked at $2K in Q3 2018. 271 funds tracked by Wall St. Rank hold INGN as of Q4 2018.

Ballew Advisors reported no remaining Inogen position as of Q4 2018 after selling out during the quarter.
Ballew Advisors sold 10 Inogen shares in Q4 2018, an estimated $2K.
Ballew Advisors first reported a position in Inogen in Q3 2018 and held it in 1 quarter.
Ballew Advisors's Inogen position peaked at $2K in Q3 2018.
271 funds tracked by Wall St. Rank held Inogen as of Q4 2018.

Based on Ballew Advisors's 13F filing for Q4 2018, filed 12 Feb 2019.